Management of osteonecrosis of the jaws in... (2010 study) Skip to main content
Case Report J Craniofac Surg 2010

Management of osteonecrosis of the jaws in patients with history of bisphosphonates therapy

Antonini F, Pereira C, Parente E, Azambuja F, J Craniofac Surg, 2010

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The authors described one patient with moderate jaw bone death linked to bisphosphonate drugs and discussed how surgery, platelet-rich plasma, hyperbaric oxygen therapy and stopping the drug might fit into care.

What They Found

This case report describes one person with moderate osteonecrosis of the upper jaw that was induced by bisphosphonates, and it discusses a possible role for combined management. The abstract gives no numbers, no outcome measures and no HBOT protocol details such as pressure or number of sessions. It says there is no consensus on an ideal treatment for this condition. It also says that preventing jaw osteonecrosis is the standard goal that researchers agree on, and that current treatment has proven to be suboptimal.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This is a single case report with no comparison group and no reported results, and because several treatments were discussed together, the abstract cannot show which one, if any, made a difference.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Report
Category Wound Care
Source Pubmed
PubMed ID 21119470
Year Published 2010
Journal J Craniofac Surg
MeSH Terms Absorbable Implants; Aged; Anti-Bacterial Agents; Bone Density Conservation Agents; Cephalexin; Combined Modality Therapy; Debridement; Diphosphonates; Female; Follow-Up Studies; Humans; Hyperbaric Oxygenation; Imidazoles; Maxillary Diseases; Membranes, Artificial; Osteonecrosis; Osteosclerosis; Patient Care Team; Platelet-Rich Plasma; Treatment Outcome; Wound Healing; Zoledronic Acid

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology